Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

281 trials

NCT07123519
Recruiting
A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases
Phase 1 · China · 1 site
Registry update: 21 Oct 2026
NCT07043153
Recruiting
AGR+PNI as Predictors of Systemic Lupus Erythematosus Disease Activity
Not applicable · Egypt · 1 site
Registry update: 13 May 2026
NCT07038382
Recruiting
A Study to Evaluate the Efficacy, Safety, and Tolerability of Human Sialidase Fusion Protein (HLX79) in Combination With Rituximab Injection Versus Placebo in Patients With Active Glomerulonephritis
Phase 2 · China · 17 sites
Registry update: 18 Nov 2025
NCT07104721
Recruiting
A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
Phase 1 · China · 1 site
Registry update: 21 Oct 2026
2024-519532-16-00
Recruiting
A phase I/II study of CAR-expressing Allogenic iPSC derived NK cells for treatment of autoiMmune disease by B cELl depletion - CARAMEL
Phase 1/2 · Germany · 1 site
Registry update: 29 May 2026
NCT06987565
Recruiting
Transcutaneous Vagus Nerve Stimulation in SLE
Phase 2 · United States · 1 site
Registry update: 17 Sept 2026
NCT07052565
Recruiting
CAR-T Cells Therapy for Patients With Autoimmune Diseases
Not applicable · China · 1 site
Registry update: 8 Jul 2025
NCT06570798
Recruiting
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
Phase 2 · United Arab Emirates, Australia, Belgium, Germany, Spain, France, United Kingdom, Italy, Portugal, United States · 56 sites
Registry update: 5 Oct 2026
NCT07031713
Recruiting
Safety, Efficacy and Cellular Metabolic Dynamics of ct1192 in Patients With Moderate to Severe Refractory SLE
Phase 1 · China · 1 site
Registry update: 24 Nov 2025
NCT07011043
Recruiting
A Phase 1b Study of Budoprutug in Systemic Lupus Erythematosus (SLE)
Phase 1 · Bulgaria, Spain, Georgia, Greece, Puerto Rico, Romania, Ukraine, United States · 18 sites
Registry update: 27 Mar 2026
NCT06659029
Recruiting
Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users
Not applicable · United States · 1 site
Registry update: 2 Sept 2026
NCT07056621
Recruiting
Does Belimumab Modify the Natural History of SLE? A Propensity Score-matched, Real-world Study
Not applicable · Greece · 1 site
Registry update: 8 Sept 2025
NCT07041801
Recruiting
Treatment of Systemic Lupus Erythematosus With Human Umbilical Cord Mesenchymal Stem Cells
Phase 1/2 · China · 1 site
Registry update: 27 Jun 2025
NCT06892145
Recruiting
Clinical Trial of CD19 Targeted CAR-T Cell in Refractory Adult SLE
Phase 1 · China · 2 sites
Registry update: 22 Dec 2025
NCT07397728
Recruiting
" TREX1 Gene Mutations and Their Role in Systemic Lupus Erythematosus
Not applicable · Egypt · 1 site
Registry update: 9 Feb 2026
NCT06857214
Recruiting
A Study of GNC-038 Tetra-specific Antibody Injection in Patients With Systemic Lupus Erythematosus
Phase 1 · China · 1 site
Registry update: 10 Jul 2026
NCT06980597
Recruiting
A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases
Phase 1 · China · 2 sites
Registry update: 20 May 2025
NCT06711887
Recruiting
Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)
Phase 3 · Brazil, China, Colombia, Czechia, Spain, France, Guatemala, Hong Kong, Hungary, South Korea, Lithuania, Mexico, Malaysia, Romania, Singapore, Thailand, Taiwan, United States, Vietnam · 53 sites
Registry update: 9 Nov 2026
NCT06881290
Recruiting
Vunakizumab for the Treatment of Mild to Moderate Systemic Lupus Erythematosus
Phase 1 · China · 1 site
Registry update: 10 Jul 2025
NCT06978647
Recruiting
A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases
Phase 1 · China · 1 site
Registry update: 21 Oct 2026

Ordered by registry start date. Freshness and sponsorship never change the order.